Surgical Science Sweden AB (publ) (FRA:4P41)

Germany flag Germany · Delayed Price · Currency is EUR
3.184
+0.068 (2.18%)
Last updated: Dec 5, 2025, 9:59 AM CET
-74.97%
Market Cap 156.10M
Revenue (ttm) 88.19M
Net Income (ttm) 6.32M
Shares Out n/a
EPS (ttm) 0.12
PE Ratio 24.71
Forward PE 13.15
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 185
Open 3.148
Previous Close 3.116
Day's Range 3.134 - 3.184
52-Week Range 2.510 - 17.220
Beta n/a
RSI 20.46
Earnings Date Feb 19, 2026

About FRA:4P41

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1997
Employees 274
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4P41
Full Company Profile

Financial Performance

In 2024, FRA:4P41's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.